Global Next-Generation Tumor Genetic Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Next-Generation Tumor Genetic Testing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Next-Generation Tumor Genetic Testing industry chain, the market status of Hospitals (Fluorescence In Situ Hybridization, Polymerase Chain Reaction), Speciality Clinics (Fluorescence In Situ Hybridization, Polymerase Chain Reaction), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Next-Generation Tumor Genetic Testing.
Regionally, the report analyzes the Next-Generation Tumor Genetic Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Next-Generation Tumor Genetic Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Next-Generation Tumor Genetic Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Next-Generation Tumor Genetic Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Fluorescence In Situ Hybridization, Polymerase Chain Reaction).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Next-Generation Tumor Genetic Testing market.
Regional Analysis: The report involves examining the Next-Generation Tumor Genetic Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Next-Generation Tumor Genetic Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Next-Generation Tumor Genetic Testing:
Company Analysis: Report covers individual Next-Generation Tumor Genetic Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Next-Generation Tumor Genetic Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Speciality Clinics).
Technology Analysis: Report covers specific technologies relevant to Next-Generation Tumor Genetic Testing. It assesses the current state, advancements, and potential future developments in Next-Generation Tumor Genetic Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Next-Generation Tumor Genetic Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Next-Generation Tumor Genetic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Next-Generation Tumor Genetic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next-Generation Tumor Genetic Testing, with revenue, gross margin and global market share of Next-Generation Tumor Genetic Testing from 2019 to 2024.
Chapter 3, the Next-Generation Tumor Genetic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Next-Generation Tumor Genetic Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Next-Generation Tumor Genetic Testing.
Chapter 13, to describe Next-Generation Tumor Genetic Testing research findings and conclusion.
The Global Info Research report includes an overview of the development of the Next-Generation Tumor Genetic Testing industry chain, the market status of Hospitals (Fluorescence In Situ Hybridization, Polymerase Chain Reaction), Speciality Clinics (Fluorescence In Situ Hybridization, Polymerase Chain Reaction), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Next-Generation Tumor Genetic Testing.
Regionally, the report analyzes the Next-Generation Tumor Genetic Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Next-Generation Tumor Genetic Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Next-Generation Tumor Genetic Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Next-Generation Tumor Genetic Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Fluorescence In Situ Hybridization, Polymerase Chain Reaction).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Next-Generation Tumor Genetic Testing market.
Regional Analysis: The report involves examining the Next-Generation Tumor Genetic Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Next-Generation Tumor Genetic Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Next-Generation Tumor Genetic Testing:
Company Analysis: Report covers individual Next-Generation Tumor Genetic Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Next-Generation Tumor Genetic Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Speciality Clinics).
Technology Analysis: Report covers specific technologies relevant to Next-Generation Tumor Genetic Testing. It assesses the current state, advancements, and potential future developments in Next-Generation Tumor Genetic Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Next-Generation Tumor Genetic Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Next-Generation Tumor Genetic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Fluorescence In Situ Hybridization
- Polymerase Chain Reaction
- Microarray Technology
- Serum Proteomics
- Nucleic Acid Sequencing
- Hospitals
- Speciality Clinics
- Research Institutes
- Diagnostics Laboratories
- Biopharmaceutical Companies
- Devyser
- Agendia
- Illumina
- Personal Genome Diagnostics
- Veracyte
- Pacific Biosciences of California
- Qiagen
- Agilent Technologies
- Natera
- Bio Rad Laboratories
- Myriad Genetics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Next-Generation Tumor Genetic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next-Generation Tumor Genetic Testing, with revenue, gross margin and global market share of Next-Generation Tumor Genetic Testing from 2019 to 2024.
Chapter 3, the Next-Generation Tumor Genetic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Next-Generation Tumor Genetic Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Next-Generation Tumor Genetic Testing.
Chapter 13, to describe Next-Generation Tumor Genetic Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Next-Generation Tumor Genetic Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Next-Generation Tumor Genetic Testing by Type
1.3.1 Overview: Global Next-Generation Tumor Genetic Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type in 2023
1.3.3 Fluorescence In Situ Hybridization
1.3.4 Polymerase Chain Reaction
1.3.5 Microarray Technology
1.3.6 Serum Proteomics
1.3.7 Nucleic Acid Sequencing
1.4 Global Next-Generation Tumor Genetic Testing Market by Application
1.4.1 Overview: Global Next-Generation Tumor Genetic Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Speciality Clinics
1.4.4 Research Institutes
1.4.5 Diagnostics Laboratories
1.4.6 Biopharmaceutical Companies
1.5 Global Next-Generation Tumor Genetic Testing Market Size & Forecast
1.6 Global Next-Generation Tumor Genetic Testing Market Size and Forecast by Region
1.6.1 Global Next-Generation Tumor Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Next-Generation Tumor Genetic Testing Market Size by Region, (2019-2030)
1.6.3 North America Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
1.6.6 South America Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Devyser
2.1.1 Devyser Details
2.1.2 Devyser Major Business
2.1.3 Devyser Next-Generation Tumor Genetic Testing Product and Solutions
2.1.4 Devyser Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Devyser Recent Developments and Future Plans
2.2 Agendia
2.2.1 Agendia Details
2.2.2 Agendia Major Business
2.2.3 Agendia Next-Generation Tumor Genetic Testing Product and Solutions
2.2.4 Agendia Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Agendia Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Next-Generation Tumor Genetic Testing Product and Solutions
2.3.4 Illumina Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Personal Genome Diagnostics
2.4.1 Personal Genome Diagnostics Details
2.4.2 Personal Genome Diagnostics Major Business
2.4.3 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Product and Solutions
2.4.4 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Personal Genome Diagnostics Recent Developments and Future Plans
2.5 Veracyte
2.5.1 Veracyte Details
2.5.2 Veracyte Major Business
2.5.3 Veracyte Next-Generation Tumor Genetic Testing Product and Solutions
2.5.4 Veracyte Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Veracyte Recent Developments and Future Plans
2.6 Pacific Biosciences of California
2.6.1 Pacific Biosciences of California Details
2.6.2 Pacific Biosciences of California Major Business
2.6.3 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Product and Solutions
2.6.4 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Pacific Biosciences of California Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Next-Generation Tumor Genetic Testing Product and Solutions
2.7.4 Qiagen Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 Agilent Technologies
2.8.1 Agilent Technologies Details
2.8.2 Agilent Technologies Major Business
2.8.3 Agilent Technologies Next-Generation Tumor Genetic Testing Product and Solutions
2.8.4 Agilent Technologies Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Agilent Technologies Recent Developments and Future Plans
2.9 Natera
2.9.1 Natera Details
2.9.2 Natera Major Business
2.9.3 Natera Next-Generation Tumor Genetic Testing Product and Solutions
2.9.4 Natera Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Natera Recent Developments and Future Plans
2.10 Bio Rad Laboratories
2.10.1 Bio Rad Laboratories Details
2.10.2 Bio Rad Laboratories Major Business
2.10.3 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Product and Solutions
2.10.4 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bio Rad Laboratories Recent Developments and Future Plans
2.11 Myriad Genetics
2.11.1 Myriad Genetics Details
2.11.2 Myriad Genetics Major Business
2.11.3 Myriad Genetics Next-Generation Tumor Genetic Testing Product and Solutions
2.11.4 Myriad Genetics Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Myriad Genetics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Next-Generation Tumor Genetic Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Next-Generation Tumor Genetic Testing by Company Revenue
3.2.2 Top 3 Next-Generation Tumor Genetic Testing Players Market Share in 2023
3.2.3 Top 6 Next-Generation Tumor Genetic Testing Players Market Share in 2023
3.3 Next-Generation Tumor Genetic Testing Market: Overall Company Footprint Analysis
3.3.1 Next-Generation Tumor Genetic Testing Market: Region Footprint
3.3.2 Next-Generation Tumor Genetic Testing Market: Company Product Type Footprint
3.3.3 Next-Generation Tumor Genetic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Next-Generation Tumor Genetic Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Next-Generation Tumor Genetic Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Next-Generation Tumor Genetic Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
6.2 North America Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
6.3 North America Next-Generation Tumor Genetic Testing Market Size by Country
6.3.1 North America Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
6.3.2 United States Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
7.2 Europe Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
7.3 Europe Next-Generation Tumor Genetic Testing Market Size by Country
7.3.1 Europe Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
7.3.3 France Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region
8.3.1 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Region (2019-2030)
8.3.2 China Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8.3.5 India Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
9.2 South America Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
9.3 South America Next-Generation Tumor Genetic Testing Market Size by Country
9.3.1 South America Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country
10.3.1 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Next-Generation Tumor Genetic Testing Market Drivers
11.2 Next-Generation Tumor Genetic Testing Market Restraints
11.3 Next-Generation Tumor Genetic Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Next-Generation Tumor Genetic Testing Industry Chain
12.2 Next-Generation Tumor Genetic Testing Upstream Analysis
12.3 Next-Generation Tumor Genetic Testing Midstream Analysis
12.4 Next-Generation Tumor Genetic Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Next-Generation Tumor Genetic Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Next-Generation Tumor Genetic Testing by Type
1.3.1 Overview: Global Next-Generation Tumor Genetic Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type in 2023
1.3.3 Fluorescence In Situ Hybridization
1.3.4 Polymerase Chain Reaction
1.3.5 Microarray Technology
1.3.6 Serum Proteomics
1.3.7 Nucleic Acid Sequencing
1.4 Global Next-Generation Tumor Genetic Testing Market by Application
1.4.1 Overview: Global Next-Generation Tumor Genetic Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Speciality Clinics
1.4.4 Research Institutes
1.4.5 Diagnostics Laboratories
1.4.6 Biopharmaceutical Companies
1.5 Global Next-Generation Tumor Genetic Testing Market Size & Forecast
1.6 Global Next-Generation Tumor Genetic Testing Market Size and Forecast by Region
1.6.1 Global Next-Generation Tumor Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Next-Generation Tumor Genetic Testing Market Size by Region, (2019-2030)
1.6.3 North America Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
1.6.6 South America Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Devyser
2.1.1 Devyser Details
2.1.2 Devyser Major Business
2.1.3 Devyser Next-Generation Tumor Genetic Testing Product and Solutions
2.1.4 Devyser Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Devyser Recent Developments and Future Plans
2.2 Agendia
2.2.1 Agendia Details
2.2.2 Agendia Major Business
2.2.3 Agendia Next-Generation Tumor Genetic Testing Product and Solutions
2.2.4 Agendia Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Agendia Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Next-Generation Tumor Genetic Testing Product and Solutions
2.3.4 Illumina Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Personal Genome Diagnostics
2.4.1 Personal Genome Diagnostics Details
2.4.2 Personal Genome Diagnostics Major Business
2.4.3 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Product and Solutions
2.4.4 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Personal Genome Diagnostics Recent Developments and Future Plans
2.5 Veracyte
2.5.1 Veracyte Details
2.5.2 Veracyte Major Business
2.5.3 Veracyte Next-Generation Tumor Genetic Testing Product and Solutions
2.5.4 Veracyte Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Veracyte Recent Developments and Future Plans
2.6 Pacific Biosciences of California
2.6.1 Pacific Biosciences of California Details
2.6.2 Pacific Biosciences of California Major Business
2.6.3 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Product and Solutions
2.6.4 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Pacific Biosciences of California Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Next-Generation Tumor Genetic Testing Product and Solutions
2.7.4 Qiagen Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 Agilent Technologies
2.8.1 Agilent Technologies Details
2.8.2 Agilent Technologies Major Business
2.8.3 Agilent Technologies Next-Generation Tumor Genetic Testing Product and Solutions
2.8.4 Agilent Technologies Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Agilent Technologies Recent Developments and Future Plans
2.9 Natera
2.9.1 Natera Details
2.9.2 Natera Major Business
2.9.3 Natera Next-Generation Tumor Genetic Testing Product and Solutions
2.9.4 Natera Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Natera Recent Developments and Future Plans
2.10 Bio Rad Laboratories
2.10.1 Bio Rad Laboratories Details
2.10.2 Bio Rad Laboratories Major Business
2.10.3 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Product and Solutions
2.10.4 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bio Rad Laboratories Recent Developments and Future Plans
2.11 Myriad Genetics
2.11.1 Myriad Genetics Details
2.11.2 Myriad Genetics Major Business
2.11.3 Myriad Genetics Next-Generation Tumor Genetic Testing Product and Solutions
2.11.4 Myriad Genetics Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Myriad Genetics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Next-Generation Tumor Genetic Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Next-Generation Tumor Genetic Testing by Company Revenue
3.2.2 Top 3 Next-Generation Tumor Genetic Testing Players Market Share in 2023
3.2.3 Top 6 Next-Generation Tumor Genetic Testing Players Market Share in 2023
3.3 Next-Generation Tumor Genetic Testing Market: Overall Company Footprint Analysis
3.3.1 Next-Generation Tumor Genetic Testing Market: Region Footprint
3.3.2 Next-Generation Tumor Genetic Testing Market: Company Product Type Footprint
3.3.3 Next-Generation Tumor Genetic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Next-Generation Tumor Genetic Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Next-Generation Tumor Genetic Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Next-Generation Tumor Genetic Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
6.2 North America Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
6.3 North America Next-Generation Tumor Genetic Testing Market Size by Country
6.3.1 North America Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
6.3.2 United States Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
7.2 Europe Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
7.3 Europe Next-Generation Tumor Genetic Testing Market Size by Country
7.3.1 Europe Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
7.3.3 France Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region
8.3.1 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Region (2019-2030)
8.3.2 China Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8.3.5 India Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
9.2 South America Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
9.3 South America Next-Generation Tumor Genetic Testing Market Size by Country
9.3.1 South America Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country
10.3.1 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Next-Generation Tumor Genetic Testing Market Drivers
11.2 Next-Generation Tumor Genetic Testing Market Restraints
11.3 Next-Generation Tumor Genetic Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Next-Generation Tumor Genetic Testing Industry Chain
12.2 Next-Generation Tumor Genetic Testing Upstream Analysis
12.3 Next-Generation Tumor Genetic Testing Midstream Analysis
12.4 Next-Generation Tumor Genetic Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Next-Generation Tumor Genetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Next-Generation Tumor Genetic Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Next-Generation Tumor Genetic Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Next-Generation Tumor Genetic Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Devyser Company Information, Head Office, and Major Competitors
Table 6. Devyser Major Business
Table 7. Devyser Next-Generation Tumor Genetic Testing Product and Solutions
Table 8. Devyser Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Devyser Recent Developments and Future Plans
Table 10. Agendia Company Information, Head Office, and Major Competitors
Table 11. Agendia Major Business
Table 12. Agendia Next-Generation Tumor Genetic Testing Product and Solutions
Table 13. Agendia Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Agendia Recent Developments and Future Plans
Table 15. Illumina Company Information, Head Office, and Major Competitors
Table 16. Illumina Major Business
Table 17. Illumina Next-Generation Tumor Genetic Testing Product and Solutions
Table 18. Illumina Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Illumina Recent Developments and Future Plans
Table 20. Personal Genome Diagnostics Company Information, Head Office, and Major Competitors
Table 21. Personal Genome Diagnostics Major Business
Table 22. Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Product and Solutions
Table 23. Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Personal Genome Diagnostics Recent Developments and Future Plans
Table 25. Veracyte Company Information, Head Office, and Major Competitors
Table 26. Veracyte Major Business
Table 27. Veracyte Next-Generation Tumor Genetic Testing Product and Solutions
Table 28. Veracyte Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Veracyte Recent Developments and Future Plans
Table 30. Pacific Biosciences of California Company Information, Head Office, and Major Competitors
Table 31. Pacific Biosciences of California Major Business
Table 32. Pacific Biosciences of California Next-Generation Tumor Genetic Testing Product and Solutions
Table 33. Pacific Biosciences of California Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Pacific Biosciences of California Recent Developments and Future Plans
Table 35. Qiagen Company Information, Head Office, and Major Competitors
Table 36. Qiagen Major Business
Table 37. Qiagen Next-Generation Tumor Genetic Testing Product and Solutions
Table 38. Qiagen Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Qiagen Recent Developments and Future Plans
Table 40. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 41. Agilent Technologies Major Business
Table 42. Agilent Technologies Next-Generation Tumor Genetic Testing Product and Solutions
Table 43. Agilent Technologies Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Agilent Technologies Recent Developments and Future Plans
Table 45. Natera Company Information, Head Office, and Major Competitors
Table 46. Natera Major Business
Table 47. Natera Next-Generation Tumor Genetic Testing Product and Solutions
Table 48. Natera Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Natera Recent Developments and Future Plans
Table 50. Bio Rad Laboratories Company Information, Head Office, and Major Competitors
Table 51. Bio Rad Laboratories Major Business
Table 52. Bio Rad Laboratories Next-Generation Tumor Genetic Testing Product and Solutions
Table 53. Bio Rad Laboratories Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Bio Rad Laboratories Recent Developments and Future Plans
Table 55. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 56. Myriad Genetics Major Business
Table 57. Myriad Genetics Next-Generation Tumor Genetic Testing Product and Solutions
Table 58. Myriad Genetics Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Myriad Genetics Recent Developments and Future Plans
Table 60. Global Next-Generation Tumor Genetic Testing Revenue (USD Million) by Players (2019-2024)
Table 61. Global Next-Generation Tumor Genetic Testing Revenue Share by Players (2019-2024)
Table 62. Breakdown of Next-Generation Tumor Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Next-Generation Tumor Genetic Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Next-Generation Tumor Genetic Testing Players
Table 65. Next-Generation Tumor Genetic Testing Market: Company Product Type Footprint
Table 66. Next-Generation Tumor Genetic Testing Market: Company Product Application Footprint
Table 67. Next-Generation Tumor Genetic Testing New Market Entrants and Barriers to Market Entry
Table 68. Next-Generation Tumor Genetic Testing Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Next-Generation Tumor Genetic Testing Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Next-Generation Tumor Genetic Testing Consumption Value Share by Type (2019-2024)
Table 71. Global Next-Generation Tumor Genetic Testing Consumption Value Forecast by Type (2025-2030)
Table 72. Global Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024)
Table 73. Global Next-Generation Tumor Genetic Testing Consumption Value Forecast by Application (2025-2030)
Table 74. North America Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Next-Generation Tumor Genetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Next-Generation Tumor Genetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Next-Generation Tumor Genetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Next-Generation Tumor Genetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Next-Generation Tumor Genetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Next-Generation Tumor Genetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Next-Generation Tumor Genetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Next-Generation Tumor Genetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Next-Generation Tumor Genetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Next-Generation Tumor Genetic Testing Raw Material
Table 105. Key Suppliers of Next-Generation Tumor Genetic Testing Raw Materials
LIST OF FIGURE
s
Figure 1. Next-Generation Tumor Genetic Testing Picture
Figure 2. Global Next-Generation Tumor Genetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type in 2023
Figure 4. Fluorescence In Situ Hybridization
Figure 5. Polymerase Chain Reaction
Figure 6. Microarray Technology
Figure 7. Serum Proteomics
Figure 8. Nucleic Acid Sequencing
Figure 9. Global Next-Generation Tumor Genetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application in 2023
Figure 11. Hospitals Picture
Figure 12. Speciality Clinics Picture
Figure 13. Research Institutes Picture
Figure 14. Diagnostics Laboratories Picture
Figure 15. Biopharmaceutical Companies Picture
Figure 16. Global Next-Generation Tumor Genetic Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Next-Generation Tumor Genetic Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market Next-Generation Tumor Genetic Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Region (2019-2030)
Figure 20. Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Region in 2023
Figure 21. North America Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Next-Generation Tumor Genetic Testing Revenue Share by Players in 2023
Figure 27. Next-Generation Tumor Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players Next-Generation Tumor Genetic Testing Market Share in 2023
Figure 29. Global Top 6 Players Next-Generation Tumor Genetic Testing Market Share in 2023
Figure 30. Global Next-Generation Tumor Genetic Testing Consumption Value Share by Type (2019-2024)
Figure 31. Global Next-Generation Tumor Genetic Testing Market Share Forecast by Type (2025-2030)
Figure 32. Global Next-Generation Tumor Genetic Testing Consumption Value Share by Application (2019-2024)
Figure 33. Global Next-Generation Tumor Genetic Testing Market Share Forecast by Application (2025-2030)
Figure 34. North America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 35. North America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 36. North America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe Next-Generation Tumor Genetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. France Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value Market Share by Region (2019-2030)
Figure 51. China Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 54. India Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 57. South America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 58. South America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 59. South America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa Next-Generation Tumor Genetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 68. Next-Generation Tumor Genetic Testing Market Drivers
Figure 69. Next-Generation Tumor Genetic Testing Market Restraints
Figure 70. Next-Generation Tumor Genetic Testing Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Next-Generation Tumor Genetic Testing in 2023
Figure 73. Manufacturing Process Analysis of Next-Generation Tumor Genetic Testing
Figure 74. Next-Generation Tumor Genetic Testing Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Table 1. Global Next-Generation Tumor Genetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Next-Generation Tumor Genetic Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Next-Generation Tumor Genetic Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Next-Generation Tumor Genetic Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Devyser Company Information, Head Office, and Major Competitors
Table 6. Devyser Major Business
Table 7. Devyser Next-Generation Tumor Genetic Testing Product and Solutions
Table 8. Devyser Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Devyser Recent Developments and Future Plans
Table 10. Agendia Company Information, Head Office, and Major Competitors
Table 11. Agendia Major Business
Table 12. Agendia Next-Generation Tumor Genetic Testing Product and Solutions
Table 13. Agendia Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Agendia Recent Developments and Future Plans
Table 15. Illumina Company Information, Head Office, and Major Competitors
Table 16. Illumina Major Business
Table 17. Illumina Next-Generation Tumor Genetic Testing Product and Solutions
Table 18. Illumina Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Illumina Recent Developments and Future Plans
Table 20. Personal Genome Diagnostics Company Information, Head Office, and Major Competitors
Table 21. Personal Genome Diagnostics Major Business
Table 22. Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Product and Solutions
Table 23. Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Personal Genome Diagnostics Recent Developments and Future Plans
Table 25. Veracyte Company Information, Head Office, and Major Competitors
Table 26. Veracyte Major Business
Table 27. Veracyte Next-Generation Tumor Genetic Testing Product and Solutions
Table 28. Veracyte Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Veracyte Recent Developments and Future Plans
Table 30. Pacific Biosciences of California Company Information, Head Office, and Major Competitors
Table 31. Pacific Biosciences of California Major Business
Table 32. Pacific Biosciences of California Next-Generation Tumor Genetic Testing Product and Solutions
Table 33. Pacific Biosciences of California Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Pacific Biosciences of California Recent Developments and Future Plans
Table 35. Qiagen Company Information, Head Office, and Major Competitors
Table 36. Qiagen Major Business
Table 37. Qiagen Next-Generation Tumor Genetic Testing Product and Solutions
Table 38. Qiagen Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Qiagen Recent Developments and Future Plans
Table 40. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 41. Agilent Technologies Major Business
Table 42. Agilent Technologies Next-Generation Tumor Genetic Testing Product and Solutions
Table 43. Agilent Technologies Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Agilent Technologies Recent Developments and Future Plans
Table 45. Natera Company Information, Head Office, and Major Competitors
Table 46. Natera Major Business
Table 47. Natera Next-Generation Tumor Genetic Testing Product and Solutions
Table 48. Natera Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Natera Recent Developments and Future Plans
Table 50. Bio Rad Laboratories Company Information, Head Office, and Major Competitors
Table 51. Bio Rad Laboratories Major Business
Table 52. Bio Rad Laboratories Next-Generation Tumor Genetic Testing Product and Solutions
Table 53. Bio Rad Laboratories Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Bio Rad Laboratories Recent Developments and Future Plans
Table 55. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 56. Myriad Genetics Major Business
Table 57. Myriad Genetics Next-Generation Tumor Genetic Testing Product and Solutions
Table 58. Myriad Genetics Next-Generation Tumor Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Myriad Genetics Recent Developments and Future Plans
Table 60. Global Next-Generation Tumor Genetic Testing Revenue (USD Million) by Players (2019-2024)
Table 61. Global Next-Generation Tumor Genetic Testing Revenue Share by Players (2019-2024)
Table 62. Breakdown of Next-Generation Tumor Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Next-Generation Tumor Genetic Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Next-Generation Tumor Genetic Testing Players
Table 65. Next-Generation Tumor Genetic Testing Market: Company Product Type Footprint
Table 66. Next-Generation Tumor Genetic Testing Market: Company Product Application Footprint
Table 67. Next-Generation Tumor Genetic Testing New Market Entrants and Barriers to Market Entry
Table 68. Next-Generation Tumor Genetic Testing Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Next-Generation Tumor Genetic Testing Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Next-Generation Tumor Genetic Testing Consumption Value Share by Type (2019-2024)
Table 71. Global Next-Generation Tumor Genetic Testing Consumption Value Forecast by Type (2025-2030)
Table 72. Global Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024)
Table 73. Global Next-Generation Tumor Genetic Testing Consumption Value Forecast by Application (2025-2030)
Table 74. North America Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Next-Generation Tumor Genetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Next-Generation Tumor Genetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Next-Generation Tumor Genetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Next-Generation Tumor Genetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Next-Generation Tumor Genetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Next-Generation Tumor Genetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Next-Generation Tumor Genetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Next-Generation Tumor Genetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Next-Generation Tumor Genetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Next-Generation Tumor Genetic Testing Raw Material
Table 105. Key Suppliers of Next-Generation Tumor Genetic Testing Raw Materials
LIST OF FIGURE
s
Figure 1. Next-Generation Tumor Genetic Testing Picture
Figure 2. Global Next-Generation Tumor Genetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type in 2023
Figure 4. Fluorescence In Situ Hybridization
Figure 5. Polymerase Chain Reaction
Figure 6. Microarray Technology
Figure 7. Serum Proteomics
Figure 8. Nucleic Acid Sequencing
Figure 9. Global Next-Generation Tumor Genetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application in 2023
Figure 11. Hospitals Picture
Figure 12. Speciality Clinics Picture
Figure 13. Research Institutes Picture
Figure 14. Diagnostics Laboratories Picture
Figure 15. Biopharmaceutical Companies Picture
Figure 16. Global Next-Generation Tumor Genetic Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Next-Generation Tumor Genetic Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market Next-Generation Tumor Genetic Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Region (2019-2030)
Figure 20. Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Region in 2023
Figure 21. North America Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Next-Generation Tumor Genetic Testing Revenue Share by Players in 2023
Figure 27. Next-Generation Tumor Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players Next-Generation Tumor Genetic Testing Market Share in 2023
Figure 29. Global Top 6 Players Next-Generation Tumor Genetic Testing Market Share in 2023
Figure 30. Global Next-Generation Tumor Genetic Testing Consumption Value Share by Type (2019-2024)
Figure 31. Global Next-Generation Tumor Genetic Testing Market Share Forecast by Type (2025-2030)
Figure 32. Global Next-Generation Tumor Genetic Testing Consumption Value Share by Application (2019-2024)
Figure 33. Global Next-Generation Tumor Genetic Testing Market Share Forecast by Application (2025-2030)
Figure 34. North America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 35. North America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 36. North America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe Next-Generation Tumor Genetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. France Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value Market Share by Region (2019-2030)
Figure 51. China Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 54. India Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 57. South America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 58. South America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 59. South America Next-Generation Tumor Genetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa Next-Generation Tumor Genetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE Next-Generation Tumor Genetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 68. Next-Generation Tumor Genetic Testing Market Drivers
Figure 69. Next-Generation Tumor Genetic Testing Market Restraints
Figure 70. Next-Generation Tumor Genetic Testing Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Next-Generation Tumor Genetic Testing in 2023
Figure 73. Manufacturing Process Analysis of Next-Generation Tumor Genetic Testing
Figure 74. Next-Generation Tumor Genetic Testing Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
